NCT00621881 A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects Status COMPLETED Phase PHASE1
NCT00588146 Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia Status TERMINATED Phase PHASE2
NCT00550849 Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction Status TERMINATED Phase PHASE1/PHASE2
NCT00492739 Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients Status RECRUITING Phase PHASE2/PHASE3
NCT00229580 Health Behavior Feedback Study for Veterans With Hepatitis C Status COMPLETED Phase PHASE1
NCT00206076 Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation Status COMPLETED Phase PHASE4
NCT00172705 Quantitative Diagnosis of Fatty Liver by Dual Energy CT Technique Status UNKNOWN Phase N/A
NCT00155376 Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography Status UNKNOWN Phase PHASE4
NCT00105235 Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients Status COMPLETED Phase PHASE2
NCT00078403 Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) Status COMPLETED Phase PHASE2
NCT00063648 Detection and Cytotoxic T Lymphocyte Therapy of Post-Transplant Lymphoproliferative Disorder After Liver Transplant Status COMPLETED Phase PHASE1
NCT00006062 Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction Status COMPLETED Phase PHASE1